Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Child Mental Health for Pediatric Clinicians

33. Advanced Q+A about Meds for ADHD, Anxiety with Dr. Jeffrey Strawn

19 Feb 2024

Description

Send us a textIt's time for some Advanced Q+A with Dr. Jeffrey Strawn about medication treatment for ADHD +/- Anxiety!?Q:? When do you use alpha agonists (like Clonidine, Guanfacine)??A:  as adjunctive treatment for kids who are having trouble tolerating stimulants,  and/or who have residual impulsivity when they're being treated with stimulants.  Q: How can you prescribe alpha-agonists to kids who cannot swallow pills?A: We've talked about the possibility of using compounding pharmacies to help create liquid formulations of certain short acting alpha agonists for kids who have trouble swallowing pills. Q: When/ would you *start* treatment for ADHD with an alpha-agonist?A: Almost Never.  Start with stimulant medication when you're considering medication treatment for ADHD, regardless of how old the child is.   So for preschool aged children with ADHD for whom you're considering medication treatment, start with stimulant medication as opposed to non-stimulant medication.  Side note: Atomoxetine or Straterra is not as effective as first-line treatments for ADHD, nor is it as effective as our first-line treatments for anxiety. And finally we covered the amazing resource of Case Studies: Stahl's Essential Psychopharmacology: Volume 4: Children and Adolescents by Jeffrey R. Strawn and Stephen M. Stahl | Nov 9, 2023 available on Amazon and through Cambridge University PressCheck out our website PsychEd4Peds.com for more resources.Follow us on Instagram @psyched4peds

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.